Informatietype:
Project
Unit:
High Tech Industry

CollaneX Therapeutics: working on a breakthrough in the fight against fibrosis

Fibrosis is the excessive formation of connective tissue in an organ or tissue; it is known from scars, but it can also occur in the liver as a result of obesity. An unhealthy lifestyle causes liver fibrosis to increase to such an extent that the disease almost begins to take on epidemic proportions, and no medicine is yet available. TNO has built up unique knowledge over the past decade that it wants to co-develop further with market parties into an effective medicine. This is currently being done by the newly founded CollaneX Therapeutics, a spin-off company of TNO. This biotech company will develop medicines against fibrosis, initially during the first phase of development independently, later in collaboration with pharmaceutical companies.

Get inspired

870 resultaten, getoond 1 t/m 5

With Urban Strategy, TNO connects with innovative U.S. West Coast in San Diego

Informatietype:
Insight
28 March 2024
Following cities like Amsterdam and Singapore, San Diego becomes the first American city to start working with TNO's Urban Strategy platform.

SWITCH field lab of TNO and Wageningen University & Research/ACRRES opened

Informatietype:
News
28 March 2024

Africa Works! 2024 Green industrialisation: Made in Africa!

Informatietype:
Event
Startdatum:
Locatie:
KIT (Royal Tropical Institute), Amsterdam

TNO launches Peregrion to boost market impact of its technology that accelerates medicine development

Informatietype:
News
25 March 2024

HY3+: ensuring security of supply of hydrogen network with neighbouring countries

Informatietype:
Article